Antibiotic Abuse Patterns in Gharbia, Egypt
Antibiotic Abuse Patterns: Medical Field And Population-Based Survey In Gharbia Governorate, Egypt
Rania Mamdouh Elkafoury
1,000 participants
May 1, 2024
OBSERVATIONAL
Conditions
Summary
Antimicrobial resistance (AMR) represents a serious problem described by the World Health Organization (WHO) as "a global public health concern". Research from around the globe indicates high rates of practices related to injudicious use of antibiotics as leftover antibiotics, antibiotic non-adherence, the pressure made by patients who request antibiotics from clinicians, unwarranted provision of antibiotics by physicians and pharmacists, antibiotic abuse and misuse in the form of overuse or underuse. Moreover, many patients believe they have the right to self-prescribe an antibiotic or get one from friends and family. About 50% of antibiotic use is done improperly using the wrong agent, dose, or duration. In Egypt, antibiotic misuse and overuse led to a high prevalence of multidrug-resistant (MDR) bacteria among the population. The current work aims to assess the prevalence of antibiotic abuse among medical field professionals and the public and understand the factors leading to antibiotic misuse, thus evaluating awareness levels regarding antibiotic resistance.
Eligibility
Inclusion Criteria3
- All medical field professionals and students with any specialty can participate in the survey
- Population more than 18 years old
- Parents of children less than 18 years old.
Exclusion Criteria2
- Participants outside the Gharbia governorate.
- Unwilling to participate
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
A questionnaire targeting a convenience sample of medical field professionals including physicians with different specialties, pharmacists, medical students, nursing staff, and the general population in Gharbia governorate (about 1000 subjects). The questionnaire will be written and digital in both Arabic and English versions. Moreover, an awareness campaign will be designed to educate the participants on appropriate antibiotic use principles.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06503055